Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Gulino

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
FEBS Letters|June 9, 2012
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domainAntonietta R Farina, Lucia Cappabianca, Natalia Di Ianni, et al.
Plos One|April 17, 2014
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotypePierdomenico Ruggeri, Antonietta R Farina, Natalia Di Ianni, et al.
Biomed Research International|July 11, 2013
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotypeAntonietta R Farina, Natalia Di Ianni, Lucia Cappabianca, et al.
Cancer Cell|March 3, 2009
Proapoptotic function of the retinoblastoma tumor suppressor proteinAlessandra Ianari, Tiziana Natale, Eliezer Calo, et al.
Experimental Cell Research|April 9, 2005
Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathwaysClaudio Talora, Samantha Cialfi, Oreste Segatto, et al.
The European Journal of Neuroscience|September 25, 2002
Tissue plasminogen activator is required for corticostriatal long-term potentiationDiego Centonze, Maddalena Napolitano, Emilia Saulle, et al.
Cancer Research|September 17, 2005
High mobility group A1 is a molecular target for MYCN in human neuroblastomaGiuseppe Giannini, Fabio Cerignoli, Massimiliano Mellone, et al.
Cell Cycle (Georgetown, Tex.)|November 27, 2013
CNBP regulates wing development in Drosophila melanogaster by promoting IRES-dependent translation of dMycLaura Antonucci, Davide D'Amico, Laura Di Magno, et al.
Molecular Carcinogenesis|March 6, 2012
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1Isabella Massimi, Francesca Guerrieri, Marialaura Petroni, et al.
European Journal of Human Genetics : EJHG|March 18, 2010
The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer casesInes Zanna, Piera Rizzolo, Francesco Sera, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
FEBS Letters|June 9, 2012
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domainAntonietta R Farina, Lucia Cappabianca, Natalia Di Ianni, et al.
Plos One|April 17, 2014
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotypePierdomenico Ruggeri, Antonietta R Farina, Natalia Di Ianni, et al.
Biomed Research International|July 11, 2013
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotypeAntonietta R Farina, Natalia Di Ianni, Lucia Cappabianca, et al.
Cancer Cell|March 3, 2009
Proapoptotic function of the retinoblastoma tumor suppressor proteinAlessandra Ianari, Tiziana Natale, Eliezer Calo, et al.
Experimental Cell Research|April 9, 2005
Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathwaysClaudio Talora, Samantha Cialfi, Oreste Segatto, et al.
The European Journal of Neuroscience|September 25, 2002
Tissue plasminogen activator is required for corticostriatal long-term potentiationDiego Centonze, Maddalena Napolitano, Emilia Saulle, et al.
Cancer Research|September 17, 2005
High mobility group A1 is a molecular target for MYCN in human neuroblastomaGiuseppe Giannini, Fabio Cerignoli, Massimiliano Mellone, et al.
Cell Cycle (Georgetown, Tex.)|November 27, 2013
CNBP regulates wing development in Drosophila melanogaster by promoting IRES-dependent translation of dMycLaura Antonucci, Davide D'Amico, Laura Di Magno, et al.
Molecular Carcinogenesis|March 6, 2012
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1Isabella Massimi, Francesca Guerrieri, Marialaura Petroni, et al.
European Journal of Human Genetics : EJHG|March 18, 2010
The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer casesInes Zanna, Piera Rizzolo, Francesco Sera, et al.
Pageof 15